Sibel Oyucu Orhan

7PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 28, 2026
Integrating Tumor Biology and Host Factors in mCRPC: The Prognostic Value of 'Time to Castration Resistance', Systemic Inflammation, and Comorbidity Burden in Patients Treated with Enzalutamide.

Seda Sali, Arife Ulaş, Sibel Oyucu Orhan

|Mar 26, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).

Erman Akkus, Mehmet Kayaalp, Müzeyyen Aslı Ergözoğlu

|Feb 27, 2026
Predicting the Unpredictable: Prognostic Role of Systemic Inflammatory Indices and Tumor Biology of Neoadjuvant Chemotherapy Response in Gastric and Gastroesophageal Junction Cancer-Insights from a Systematic Review and Real-World Experience.

Sibel Oyucu Orhan, Bedrettin Orhan, Yağmur Çakır

|Dec 31, 2025
Prognostic Value of Histological Subtypes and Clinical Factors in Non-Endemic Nasopharyngeal Carcinoma: A Retrospective Cohort Study.

Seda Sali, Candan Demiröz Abakay, Mürsel Sali

|Sep 27, 2025
Managing Bone Metastases with Denosumab: Real-World Data and Critical Monitoring Points in Breast, Lung, and Prostate Cancers.

Sibel Oyucu Orhan, Bedrettin Orhan, Şeyma Esenbuğa

|Jun 30, 2025
Primary neuroendocrine tumors of the breast according to the WHO 2019 classification; real life experiences of rare tumor types of the breast.

Seda Sali, Mursel Sali, Burcu Caner

Pageof 2

Frequent Collaborators

5 joint publications

Turkkan Evrensel

5 joint publications

Seda Sali

5 joint publications

Birol Ocak

4 joint publications

Ahmet Bilgehan Sahin